Gentile, P., Sterodimas, A. (2020). Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia. EXPERT OPINION ON BIOLOGICAL THERAPY, 20(7), 711-716 [10.1080/14712598.2020.1761322].

Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia

Gentile, Pietro
Writing – Original Draft Preparation
;
2020

Pubblicato
Rilevanza internazionale
Editoriale
Esperti anonimi
Settore MED/19
English
Con Impact Factor ISI
Mesenchymal stem cells coronavirus
adipose-derived stem cells coronavirus
cellular therapy COVID-19
mesenchymal stem cells COVID-19
stem cell therapy COVID-19
Gentile, P., Sterodimas, A. (2020). Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia. EXPERT OPINION ON BIOLOGICAL THERAPY, 20(7), 711-716 [10.1080/14712598.2020.1761322].
Gentile, P; Sterodimas, A
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
ASCs COVID 19 EOBT.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 894.54 kB
Formato Adobe PDF
894.54 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/303516
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 48
social impact